ArticleOsteoarthritis and cartilage open2026
Investigating predictors of pain events during trials of knee osteoarthritis: A post-hoc analysis of two phase III trials.
Article in Osteoarthritis and cartilage open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to explore the associations between clinical characteristics, including medical history, and the frequency, severity, and type of pain events (PEs) over a two-year period in patients with knee osteoarthritis (OA). Design: A post-hoc analysis was conducted on data from two double-blinded, randomized, placebo-controlled, multicenter phase-III trials assessing the efficacy and safety of salmon calcitonin in patients with painful and radiographic knee OA. 2206 patients aged 51-80 years were included. Adverse events (AEs) were recorded and categorized into PEs and non-PEs. Logistic regression models were used to assess associations, adjusting for confounders such as age, sex, and body mass index (BMI). Results: Of the 8183 AEs recorded, 27.6 % were classified as PEs. Higher BMI was associated with lower odds of reporting PEs (OR: 0.94, p = 0.02), while male patients reported fewer PEs than females (OR: 0.83, p = 0.04). Insomnia and depression were linked to increased odds of PEs. In the PE population, higher BMI was associated with increased odds of moderate and severe PEs. KL grade 3 was linked to lower odds of moderate and severe PEs. Conclusions: The study identifies female sex and certain medical histories as significant predictors of PEs in knee OA patients. A higher BMI was associated with lower odds of reporting PEs but for those who reported PEs, higher BMI was associated with more severe PEs. These results should be interpreted with caution due to methodological limitations, however the findings indicate risk factors for pain events and suggest further research into these associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.